6 Reasons Why People Skip Their HIV Meds
We all know it’s important to take HIV medications every day, but let’s face it: It’s not always the easiest thing to do. Here are six key obstacles that can block the way between you and your meds – and tips on how to get past them.
Featured
Can HIV Meds Interact With COVID-19 Treatment? Here’s What We Know So Far
Whether it’s remdesivir, corticosteroids, convalescent plasma, or monoclonal antibodies, we’ve got the latest expert info on what people living with HIV and their clinicians need to keep in mind.
Atripla for HIV Treatment: Everything You Need to Know
It's the oldest single-tablet regimen for HIV. But is it washed up as a viable treatment option? Here's a top expert's take.
Genvoya for HIV Treatment: Everything You Need to Know
It’s not considered a “preferred” option for starting HIV treatment in the U.S., but Genvoya still has its place in our medication arsenal.
People with HIV Face New Challenges to Care Continuity During COVID Lockdown
The pandemic has disrupted HIV care all over the world, causing missed doses of medications and lack of access to clinics.
The Anatomy of a Slip-Up
Why do people living with HIV fall through the cracks of care despite our best efforts, and how do we prevent that during a global pandemic?
When I Say U=U, That Means You, Too
Undetectable equals untransmittable (U=U) doesn’t mean the burden of staying HIV-free is solely on positive people.
COVID-19 Doesn’t Stop HIV Support Group From ‘Living Successfully’
Zooming in on new technology, these New Yorkers battle an old problem.
Alternative COVID-19 Treatments Call Back to the Early AIDS Days
As with the early AIDS epidemic, people are turning to alternative treatments for COVID-19 in the absence of proven therapies.
What You Need to Know About the New Coronavirus and HIV
The latest medical advice from HIV doctors and health experts on how to remain healthy if you're living with HIV during this COVID-19 outbreak.
Copay Cards May No Longer Count Toward Your Health Plan Deductible
The Trump administration’s HHS has officially told plans they don’t have to do this—and that could mean a hard hit on patient wallets.